Trials / Withdrawn
WithdrawnNCT00801866
Avastin for Post-photocoagulation Macular Edema
Prevention of Post-photocoagulation Macular Edema by Intravitreal Bevacizumab.
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Asociación para Evitar la Ceguera en México · Academic / Other
- Sex
- All
- Age
- 15 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
to evaluate the efficacy of a single intravitreal bevacizumab (IVB) injection, 0.1mL (2.5mg), against panretinal photocoagulation (PRP)-induced macular thickening and visual disturbance in patients with severe nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) and good vision
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab | Intravitreal administration |
| PROCEDURE | Panretinal Photocoagulation | Panretinal Photocoagulation |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2008-12-04
- Last updated
- 2024-05-30
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00801866. Inclusion in this directory is not an endorsement.